These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2243187)

  • 1. [Comparison between two systems for assaying the level of antibody against Streptococcus agalactiae (GBS) type III].
    Hoshina K; Suzuki Y; Unno S; Kobayashi M; Matsue T; Amano Y; Onogawa T
    Kansenshogaku Zasshi; 1990 Sep; 64(9):1172-6. PubMed ID: 2243187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [ELISA for type-specific group B streptococcal antibody and its clinical significance].
    Ooe Y; Nishiyama Y; Sugiyama A; Simizu S; Kunishima S; Itou T; Sugiyama M
    Kansenshogaku Zasshi; 1990 Oct; 64(10):1251-4. PubMed ID: 2258642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Type-specific antibody to type Ia, Ib, II and III group B Streptococcus in maternal and neonatal sera measured by ELISA].
    Sugiyama M; Kojima M; Hori Y; Simizu S; Sugiyama A; Ooe Y; Nishiyama Y
    Kansenshogaku Zasshi; 1990 Sep; 64(9):1232-8. PubMed ID: 2243195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of IgM antibody to group B Streptococcus type III in human infants.
    Boyer KM; Klegerman ME; Gotoff SP
    J Infect Dis; 1992 Jun; 165(6):1049-55. PubMed ID: 1583322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
    Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B
    Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
    Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
    Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay for measurement of antibody to type III group B streptococci.
    Polin RA; Douglas SD; Kasper DL; Baker CJ
    J Clin Microbiol; 1982 Jun; 15(6):991-3. PubMed ID: 7050158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody.
    Kim KS; Wass CA; Hong JK; Concepcion NF; Anthony BF
    Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiological studies of group B Streptococcus type II.
    Gray BM; Pritchard DG; Dillon HC
    J Infect Dis; 1985 Jun; 151(6):1073-80. PubMed ID: 2582066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive procedures against GBS infection by means of antibody measurement.
    Mikamo H; Higa M; Sato Y; Hayasaki Y; Hua YX; Yasuda-Kawazoe K; Tamaya T
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2000 Aug; 11(1):33-7. PubMed ID: 11004709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitation of IgG antibodies to type Ia group B streptococcal type-specific polysaccharides measured by enzyme-linked immunosorbent assay].
    Sugiyama M; Kojima M; Yasuda Y; Hori Y; Nishiyama Y; Sugiyama A; Kido N; Ota M
    Kansenshogaku Zasshi; 1990 Jul; 64(7):840-6. PubMed ID: 2230372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
    Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
    Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative determination of antibodies to type III group B streptococcal polysaccharide.
    Guttormsen HK; Baker CJ; Edwards MS; Paoletti LC; Kasper DL
    J Infect Dis; 1996 Jan; 173(1):142-50. PubMed ID: 8537651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative measurement of group B streptococcal antibodies (serotypes Ia, Ib, II and III) in human cord sera by the indirect enzyme-linked immunosorbent assay.
    Ratei R; Kainer F; Hahn H
    Zentralbl Bakteriol; 1990 Nov; 274(2):227-38. PubMed ID: 2085372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of type-specific group B streptococcal antibody in pregnant women.
    Vogel LC; Boyer KM; Gadzala CA; Gotoff SP
    J Pediatr; 1980 Jun; 96(6):1047-51. PubMed ID: 6989972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of carrier rate and immunity to group B streptococcus (GBS) in unmarried women].
    Sugiyama A; Shiraki N; Sugiyama M; Nishiyama Y
    Nihon Koshu Eisei Zasshi; 1991 Feb; 38(2):106-11. PubMed ID: 1932783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns.
    Suara RO; Adegbola RA; Mulholland EK; Greenwood BM; Baker CJ
    J Natl Med Assoc; 1998 Feb; 90(2):109-14. PubMed ID: 9510625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses.
    Feldman RG; Ferrante A
    J Infect Dis; 1990 Oct; 162(4):883-7. PubMed ID: 2205651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults.
    Kotloff KL; Fattom A; Basham L; Hawwari A; Harkonen S; Edelman R
    Vaccine; 1996 Apr; 14(5):446-50. PubMed ID: 8735558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
    Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
    J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.